Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial

Clinical Therapeutics
G DerosaMario N Piccinni

Abstract

Glimepiride is approved as monotherapy and in combination with metformin or with insulin, whereas the combination of glimepiride with other antihyperglycemic drugs is under investigation. The aim of this study was to assess the differential effect on glucose and lipid variables and tolerability of the combination of glimepiride plus pioglitazone or rosiglitazone in patients with type 2 diabetes mellitus (DM) and metabolic syndrome. This 12-month, multicenter, double-blind, randomized, controlled, parallel-group trial was conducted at 3 study sites in Italy. We assessed patients with type 2 DM (duration, > or =6 months) and with metabolic syndrome. All patients were required to have poor glycemic control with, or to have experienced > or =1 adverse effect (AE) with, diet and oral hypoglycemic agents such as sulfonylureas or metformin, both given up to the maximum tolerated dose. All patients received a fixed oral dose of glimepiride, 4 mg/d divided into 2 doses, self-administered for 12 months. Patients also were randomized to receive oral pioglitazone (15 mg once daily) (G + P group) or oral rosiglitazone (4 mg once daily) (G + R group), self-administered for 12 months. We assessed body mass index (BMI), glycemic control (glyco...Continue Reading

References

Feb 26, 2000·Diabetic Medicine : a Journal of the British Diabetic Association·B H WolffenbuttelR N Patwardhan
Apr 15, 2000·The American Journal of Medicine·M Riddle
Feb 24, 2001·Diabetes Care·L S PhillipsUNKNOWN Rosiglitazone Clinical Trials Study Group
May 5, 2001·Expert Opinion on Pharmacotherapy·A L McCall
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Oct 26, 2002·The American Journal of Cardiology·Martin I FreedUNKNOWN Rosiglitazone Study 108 investigators
Nov 22, 2002·Current Medical Research and Opinion·Kathy Ann LaCivita, Gustavo Villarreal
Dec 12, 2002·Diabetes·Peter ProksFrances Ashcroft
Jan 22, 2003·Trends in Cardiovascular Medicine·P Zimmet
Feb 5, 2003·Current Medical Research and Opinion·Varaphon VongthavaravatUNKNOWN 125 Study Group
Mar 26, 2003·Diabetologia·L F Van Gaal, I H De Leeuw
Jun 27, 2003·Drugs·Michaela Diamant, Robert J Heine
Jul 2, 2003·Expert Opinion on Investigational Drugs·Michael Stumvoll
Jul 10, 2003·Diabetes Research and Clinical Practice·Raimund WeitgasserAnton Klingler
Jul 11, 2003·Clinical Therapeutics·Massimo Massi-Benedetti
Aug 9, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Jeroen P H van WijkTon J Rabelink
Sep 1, 1955·The Journal of Clinical Investigation·R J HAVELJ H BRAGDON

❮ Previous
Next ❯

Citations

Sep 1, 2007·Indian Journal of Clinical Biochemistry : IJCB·K T AugustiVarghese Chemmanam
Nov 2, 2006·Current Diabetes Reports·Tamara DarsowDavid Maggs
Oct 2, 2009·Current Diabetes Reports·Edoardo Mannucci, Matteo Monami
Jan 24, 2007·Nature Clinical Practice. Endocrinology & Metabolism·Philippe GervoisBart Staels
Mar 29, 2008·Metabolic Syndrome and Related Disorders·David M Kendall
Jan 4, 2007·Diabetes, Obesity & Metabolism·D P MacfarlaneM Fisher
Jul 21, 2009·Diabetes, Obesity & Metabolism·G CharpentierUNKNOWN F-PIO-100 Study Investigators
May 17, 2011·Diabetes, Obesity & Metabolism·A Chaudhuri, P Dandona
Jun 28, 2007·International Journal of Clinical Practice. Supplement·M Hanefeld
Jun 28, 2007·International Journal of Clinical Practice. Supplement·G Derosa
May 22, 2007·International Journal of Clinical Practice·R Donnelly
Jun 6, 2009·International Journal of Clinical Practice·G Schernthaner
Dec 14, 2005·Postgraduate Medical Journal·M C Marshall
Oct 26, 2010·Journal of Lipid Research·John S MillarDaniel J Rader
Mar 25, 2006·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Giuseppe DerosaRoberto Fogari
Mar 10, 2007·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Giuseppe DerosaRoberto Fogari
Jun 26, 2007·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Giuseppe DerosaRoberto Fogari
Jan 1, 2009·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Giuseppe Derosa, Sibilla At Salvadeo
Jun 22, 2007·Vascular Health and Risk Management·Andreas PfütznerThomas Forst
Oct 17, 2006·Drugs·Emma D Deeks, Lesley J Scott
Sep 29, 2011·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Giuseppe Derosa
Mar 3, 2009·Internal Medicine·Giuseppe DerosaArrigo F G Cicero
Mar 20, 2010·Current Medical Research and Opinion·Angel RodríguezJesús Reviriego
May 11, 2005·Current Medical Research and Opinion·Rukmini RajagopalanMehmood Khan
Apr 7, 2005·Current Medical Research and Opinion·E Erdmann
Apr 7, 2005·Current Medical Research and Opinion·B Vergès
Nov 13, 2009·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Giuseppe DerosaArrigo F G Cicero
Feb 6, 2007·Diabetes Research and Clinical Practice·Masahiko IgarashiMakoto Tominaga

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.